Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

Ratios

vs
industry
vs
history
P/E(ttm) 15.53
PID's P/E(ttm) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 15.53 )
Ranked among companies with meaningful P/E(ttm) only.
PID' s P/E(ttm) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 15.65
Current: 15.53
0
15.65
PE(NRI) 15.53
PID's PE(NRI) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 15.53 )
Ranked among companies with meaningful PE(NRI) only.
PID' s PE(NRI) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 15.65
Current: 15.53
0
15.65
P/B 1.47
PID's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 1.47 )
Ranked among companies with meaningful P/B only.
PID' s P/B Range Over the Past 10 Years
Min: 0  Med: 0 Max: 1.48
Current: 1.47
0
1.48

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 3.77
PID's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 3.77 )
Ranked among companies with meaningful Dividend Yield only.
PID' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0 Max: 3.78
Current: 3.77
0
3.78
Yield on cost (5-Year) 3.77
PID's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 3.77 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
PID' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 3.78
Current: 3.77
0
3.78

More Statistics

Short Percentage of Float0.00%
52-Week Range $11.44 - 15.65
Shares Outstanding (Mil)46,450,000.00
» More Articles for PID

Headlines

Articles On GuruFocus.com
Brandes Funds Comments on Ericsson Aug 24 2016 
Brandes Funds Comments on Fuji Media Holdings Aug 24 2016 
Housing Market at New Levels Aug 24 2016 
Brandes Funds Comments on Nokia Aug 24 2016 
Brandes Funds Comments on Embraer Aug 24 2016 
Thomas Greco Buys Advance Auto Parts Aug 24 2016 
Brandes Funds Comments on Kasikornbank Aug 24 2016 
Brandes Funds Comments on Bangkok Bank Aug 24 2016 
Brandes Funds Comments on Companhia de Saneamento Basico do Estado de Sao Paulo Aug 24 2016 
Brandes Funds Comments on Eletrobras Aug 24 2016 

More From Other Websites
Teva Pharmaceutical: A Successful Bond Financing Program in 2016 Aug 22 2016
How Merial Contributes to Sanofi’s Growth Aug 22 2016
What Happened to Sanofi’s Consumer Healthcare and Generics Franchise in 2Q16? Aug 19 2016
Behind Sanofi’s Diabetes and Cardiovascular Performance in 2Q16 Aug 18 2016
Genzyme Continued to Boost Growth for Sanofi in 2Q16 Aug 18 2016
Inside Sanofi’s Valuation Changes Aug 17 2016
How Did Novo Nordisk Perform across Geographies in 1H16? Aug 09 2016
A New Low Volatile International ETF for Dividend Lovers Aug 08 2016
A New Low Volatility International ETF for Dividend Lovers Aug 08 2016
An Update on Shire’s Upcoming Milestones Aug 05 2016
How Did GlaxoSmithKline’s Pharmaceuticals Segment Do in 2Q16? Aug 02 2016
How Much Growth Will Novo See in 2Q16? Aug 01 2016
GlaxoSmithKline Increases Top Line in 2Q16 Jul 30 2016
What to Expect from Shire’s Genetic Disease Franchise Jul 28 2016
What Role Did Innovative Medicines Play in Novartis’s 2Q16 Earnings? Jul 22 2016
How Did Novartis’s 2Q16 Earnings Stand up to Analyst Estimates? Jul 21 2016
Novartis’s 2Q16 Earnings: What’s Expected? Jul 18 2016
How Could the Novartis-Xencor Alliance Benefit Novartis? Jul 01 2016
What Is Xencor’s XmAb Technology? Jun 30 2016
A New Idea Among International Dividend ETFs Jun 30 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK